Wednesday, October 09, 2019 3:17:39 PM
A pump will only occur if they've generated new business, which could be happening, but not within a Q Report. A PR based on a Q Report would only contain "foreward looking statements," to protect themselves legally with the SEC.
That's not to say that new business may or may not be in the works, just that if it were, it wouldn't show up in a Q Report, unless money has already changed hands - deposits, loans, revenues. If so, great, if not, then reduction of debt or expenses is good, but since fiscal responsibity is expected business behavior, meeting that expectation wouldn't create an uptick.
A "new business" PR can come at any point, and will be when you least expect it. That's the biggest bang for the buck.
Once new business is realized (an actual signed contract), there's the pump. For a genuine pump, the logical usual strategy is to have a positive PR "foreward statement" on a "pending deal" (that they already signed behind curtains), to generate interest. Then roll it out a week or so later, while everyone's still watching, with a big, "GXXM Makes Deal" PR announcement. Boom!
Go GXXM!
Recent GXXM News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:53 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 11/13/2023 09:11:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 08:38:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:22:30 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/21/2023 08:00:34 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 02:09:47 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM